APA (7th ed.) Citation

Bloos, F., Held, J., Schlattmann, P., Brillinger, N., Kurzai, O., Cornely, O. A., & Thomas-Rüddel, D. (2018). (1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with sepsis and with an increased risk of invasive Candida infection (CandiSep): Study protocol for a randomized controlled trial. Trials, 19(1), N.PAG. https://doi.org/10.1186/s13063-018-2868-0

Chicago Style (17th ed.) Citation

Bloos, Frank, Jürgen Held, Peter Schlattmann, Nicole Brillinger, Oliver Kurzai, Oliver A. Cornely, and Daniel Thomas-Rüddel. "(1,3)-β-D-glucan-based Diagnosis of Invasive Candida Infection Versus Culture-based Diagnosis in Patients with Sepsis and with an Increased Risk of Invasive Candida Infection (CandiSep): Study Protocol for a Randomized Controlled Trial." Trials 19, no. 1 (2018): N.PAG. https://doi.org/10.1186/s13063-018-2868-0.

MLA (9th ed.) Citation

Bloos, Frank, et al. "(1,3)-β-D-glucan-based Diagnosis of Invasive Candida Infection Versus Culture-based Diagnosis in Patients with Sepsis and with an Increased Risk of Invasive Candida Infection (CandiSep): Study Protocol for a Randomized Controlled Trial." Trials, vol. 19, no. 1, 2018, p. N.PAG, https://doi.org/10.1186/s13063-018-2868-0.